Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2009 R21 RFA-CA-08-007 TAINSKY, MICHAEL A WAYNE STATE UNIVERSITY SERUM BIOMARKERS FOR COLORECTAL CANCER DETECTION Complete
2013 R21 RFA-CA-13-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES COMPACT MICROFLUIDIC PET PROBE CONCENTRATOR FOR PRECLINICAL AND IN VITRO IMAGING Complete
2016 R21 RFA-CA-15-004 GARCIA, ANDRES J GEORGIA INSTITUTE OF TECHNOLOGY USHEAR TECHNOLOGY FOR CANCER CELL PURIFICAITON Complete
2000 R33 PAR-98-067 HUANG, TIM H.-M. UNIVERSITY OF MISSOURI-COLUMBIA HIGH THROUGHPUT METHYLATION ANALYSIS IN CANCER Complete
2002 R33 PAR-99-100 CHURCHILL, GARY A JACKSON LABORATORY EXPERIMENTAL DESIGN & ANALYSIS FOR EXPRESSION MICROARRAY Complete
2006 R21 RFA-CA-06-002 WOODS, VIRGIL L UNIVERSITY OF CALIFORNIA SAN DIEGO DXMS-FACILITATED MEMBRANE PROTEIN CONSTRUCT DESIGN/CANCER Complete
2008 R43 RFA-CA-07-039 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. ABSCRIPTION?-BASED CPG METHYLATION ASSAYS FOR EARLY CANCER DETECTION Complete
2011 R43 RFA-CA-10-013 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2015 R43 PAR-13-327 MANDECKI, WLODEK PHARMASEQ, INC. SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT Complete
2019 R21 RFA-CA-18-002 WU, YUN STATE UNIVERSITY OF NEW YORK AT BUFFALO Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Complete
2000 R21 PAR-98-067 CHANCE, MARK R YESHIVA UNIVERSITY DYNAMICS OF MACROMOLECULAR INTERACTIONS Complete
2002 R21 PAR-01-106 KENAN, DANIEL J. DUKE UNIVERSITY ENDOTHELIAL CELL MOLECULAR ALTERATIONS IN CANCER Complete
2005 R21 RFA-CA-05-002 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT IDENTIFICATION OF IMMUNE SELECTED BREAST CANCER ANTIGENS Complete
2008 R21 RFA-CA-07-033 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE TIME-RESOLVED FLUOROMETRIC METHOD FOR ASSAY OF MULTIPLE BIOMARKERS Complete
2011 R21 RFA-CA-10-003 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2015 R21 RFA-CA-14-003 HAYDEN, MELANIE STANFORD UNIVERSITY CELL-FREE TUMOR DNA IN CEREBRAL SPINAL FLUID DECODES TUMORS OF THE CENTRAL NERVOUS SYSTEM Complete
2018 R21 RFA-CA-17-010 SCHIBEL, ANNA ELECTRONIC BIOSCIENCES, INC. Microsatellite Sequencing to Enable Cancer Genotyping Complete
1999 R21 PAR-98-067 MEYER, TOBIAS DUKE UNIVERSITY CELL ARRAYS FOR SCREENING SIGNAL TRANSDUCTION PROCESSES Complete
2001 R33 PAR-99-102 MORRIS, DAVID R UNIVERSITY OF WASHINGTON DEVELOPMENT OF TRANSLATION STATE ARRAY ANALYSIS Complete
2004 R21 PAR-01-106 SIMS, CHRISTOPHER E UNIVERSITY OF CALIFORNIA IRVINE ASSAYING TYROSINE KINASE ACTIVITY: A NEW PARADIGM Complete
2007 R21 RFA-CA-07-015 WANG, NICHOLAS J UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB NANO-SCALE DETECTION OF THE DISEASE PROTEOME Complete
2010 R21 RFA-CA-09-008 BARRETT, MICHAEL T TRANSLATIONAL GENOMICS RESEARCH INST HIGH DEFINITION CLONAL ANALYSES OF ARCHIVAL PANCREATIC ADENOCARCINOMA SAMPLES Complete
2014 R21 RFA-CA-13-001 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE INTEGRATED MICROFLUIDIC EXOSOME PROFILING FOR EARLY DETECTION OF CANCER Complete
2017 R21 RFA-CA-16-001 SOELLNER, MATTHEW B UNIVERSITY OF MICHIGAN AT ANN ARBOR Exquisitely selective turn-on probes of kinase activation and localization Complete
2001 R21 PAR-99-100 YAMAMOTO, FUMIICHIRO BURNHAM INSTITUTE FOR MEDICAL RESEARCH TECHNOLOGY TO DETECT GENOME WIDE DNA METHYLATION CHANGES Complete
2003 R21 PAR-01-104 GOODLETT, DAVID ROBINSON INSTITUTE FOR SYSTEMS BIOLOGY PARALLEL PEPTIDE TANDEM MASS SPECTROMETRY (MS) Complete
2006 R43 RFA-CA-06-005 MOON, JOHN A ILLUMINA, INC. MICROFLUIDIC CAPILLARY ASSAY UTILIZING HOLOGRAPHICALLY * Complete
2009 R21 RFA-CA-08-007 SODERLING, SCOTT H. DUKE UNIVERSITY MAPPING THE ARCHITECTURE OF CANCER SIGNALING PATHWAYS Complete
2013 R21 RFA-CA-13-001 WANG, ANDREW ZHUANG UNIV OF NORTH CAROLINA CHAPEL HILL DEVELOPMENT OF 3D ORGAN-SPECIFIC MODELS OF COLORECTAL CANCER METASTASIS Complete
2016 R21 RFA-CA-15-004 JAHNKE, FRANK SONATA BIOSCIENCES, INC. A NEW SAMPLE PREPARATION METHOD TO DELVE DEEPER INTO THE PROTEOME Complete
2000 R33 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2002 R33 PAR-99-100 FRANK-KAMENETSKII, MAXIM D BOSTON UNIVERSITY STUDIES OF HEMATOLOGIC MALIGNANCIES BY PNA TECHNOLOGY Complete
2006 R21 RFA-CA-06-002 LARGAESPADA, DAVID ANDREW UNIVERSITY OF MINNESOTA TWIN CITIES TRANSPOSON-BASED SOMATIC MUTAGENESIS/PROSTATE CANCER GENETICS Complete
2008 R43 RFA-CA-07-041 MATHEW, ANU MESO SCALE DIAGNOSTICS, LLC MULTIPLEXED BIOMARKER PANELS FOR EARLY DETECTION OF PROSTATE CANCER Complete
2011 R43 RFA-CA-10-013 RUAN, BIAO POTOMAC AFFINITY PROTEINS, LLC PROTEASE CHAIN REACTIONS FOR MOLECULAR ANALYSIS OF CANCER MARKERS Complete
2015 R43 PAR-13-327 JIANG, LI A'AS, INC. KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA Complete
2019 R21 RFA-CA-18-002 ZHU, YAZHEN UNIVERSITY OF CALIFORNIA LOS ANGELES Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs Complete
2021 R21 CA20-019 NAUTIYAL, SHIVANI PRIME GENOMICS, INC. Device for Preservation of Cell Free RNA in Saliva NCE
2021 R21 CA20-017 FARIS, GREGORY W NUMENTUS TECHNOLOGIES INC. Decoding Individual Exosomes in Cancer NCE
2021 R21 CA20-017 DEININGER, MICHAEL W VERSITI WISCONSIN, INC. A Bioluminescent Assay for Direct Measurement of Sirtuin Activity in Cancer Cells NCE
2020 R21 RFA-CA-19-019 REVZIN, ALEXANDER MAYO CLINIC ROCHESTER A microfluidic cell culture platform for personalizing pancreatic cancer therapies NCE
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics NCE
2020 R33 RFA-CA-19-020 LEVINSON, NICHOLAS MARK UNIVERSITY OF MINNESOTA Time-resolved FRET-based allostery sensors for any protein kinase drug target NCE

Pages